Clin2
NCT07423312Possibly a fitNot yet recruiting

Lead exposure and multiple sclerosis

Multiple Sclerosis

Part of Brain & nervous system, Immune system & allergy clinical trials.

This study looks at whether lead exposure is linked to multiple sclerosis (MS). If you join, researchers may test your lead levels to see if there's a connection with your MS.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
20 years to 50 years
Study type
Observational

Who can take part

  • You must be between 20 and 50 years old.
  • You must have a confirmed multiple sclerosis (MS) diagnosis using the McDonald criteria.
  • You must NOT have any other autoimmune disease (like lupus or rheumatoid arthritis).
  • You must NOT have chronic kidney or liver disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01353547Recruiting
Study genes and environment in multiple sclerosis risk

This study looks at how genes and life exposures may relate to developing multiple sclerosis (MS) or to MS itself. You may be invited if you have a specific connection to MS or certain past immune-related treatments.

Bethesda, Maryland
NCT07645703Not yet recruiting
Multiple sclerosis health study

This study follows people with multiple sclerosis over time to learn more about the disease and improve care. If you join, you will help researchers understand MS better, which could lead to better treatments.

NCT05787795Recruiting
Studying early risk signs for multiple sclerosis

This study looks at people who are at higher risk for multiple sclerosis (MS), to better understand early changes before MS is diagnosed. It may help doctors identify who is more likely to develop MS and how to monitor them sooner.

North Haven, Connecticut
NCT04604041Recruiting
Study early warning signs in relapsing-remitting multiple sclerosis

This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.

Split
NCT03217396Recruiting
Study blood and MRI markers in people with multiple sclerosis

This study looks for signs of “synapse damage” in multiple sclerosis using blood tests and brain imaging (MRI). The goal is to find biomarkers that may help better understand MS and how it changes over time.

Pozzilli, Isernia
NCT02994121Recruiting
Study of multiple sclerosis in the Three Rivers region

This study follows people with multiple sclerosis (MS) and some healthy people in the local area to better understand MS and related nerve conditions. It may help researchers learn which symptoms and scan changes show up over time.

Pittsburgh, Pennsylvania

Hear when a new Multiple sclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.